An Observational, Long-Term Extension Study for Participants in Prior VY-AADC01 Clinical Studies
Sponsor:
Neurocrine Biosciences
Brief Summary:
An extension study for participants who have completed a prior VY-AADC01 clinical study
Criteria
Key Inclusion Criteria:
1. Completed participation in the PD-1101 or PD-1102 clinical study of VY-AADC01 gene
therapy
Key Exclusion Criteria:
None
Locations
- University of California, San Francisco, San Francisco, California, United States, 94143
